GGrantIndex
← Leaderboards

Parag Kumar Mallick

Massachusetts Institute Of Technology

$7,338,792
Attributed
$11,247,678
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,247,678 · 6

By mechanism

R01$10,007,238 · 4
R21$745,854 · 1
U54$494,586 · 1

Most similar at Massachusetts Institute Of Technology

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics

Research focus

ProteomicsEnvironmentCellsProteinsMolecularDensityMalignant NeoplasmsImagePathway InteractionsImaging DeviceCell TypeBaseNeighborhoodsFutureMachine LearningPatternDetectionResolutionMorphologySignal PathwayPhenotypeAlzheimer&AposImmunofluorescence ImmunologicValidation

Grant awards (24)

Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$807,254
R01 · FY2025 · AG
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles$626,777
R01 · FY2025 · CA
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$94,829
R01 · FY2025 · AG
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$819,435
R01 · FY2024 · AG
Pathomic Predictors of Prostate Cancer Progression$690,744
R01 · FY2024 · CA · contact PI
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles$643,522
R01 · FY2024 · CA
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$71,342
R01 · FY2024 · AG
Pathomic Predictors of Prostate Cancer Progression$895,176
R01 · FY2023 · CA · contact PI
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$860,474
R01 · FY2023 · AG
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$880,858
R01 · FY2022 · AG
Pathomic Predictors of Prostate Cancer Progression$821,911
R01 · FY2022 · CA · contact PI
Pathomic Predictors of Prostate Cancer Progression$795,107
R01 · FY2021 · CA · contact PI
Pathomic Predictors of Prostate Cancer Progression$910,446
R01 · FY2020 · CA · contact PI
A Discovery Engine For Reproducible and Comparable Multi-Omic Analysis$349,758
R01 · FY2018 · GM · contact PI
A Discovery Engine For Reproducible and Comparable Multi-Omic Analysis$358,203
R01 · FY2017 · GM · contact PI
A Discovery Engine For Reproducible and Comparable Multi-Omic Analysis$381,402
R01 · FY2016 · GM · contact PI
Outreach and Dissemination Unit$95,029
U54 · FY2013 · CA · contact PI
Outreach and Dissemination Unit$98,938
U54 · FY2012 · CA · contact PI
Developing a single cell growth monitor for classifying therapeutic response$141,902
R21 · FY2011 · CA
Outreach and Dissemination Unit$98,619
U54 · FY2011 · CA · contact PI
Developing a single cell growth monitor for classifying therapeutic response$293,446
R21 · FY2010 · CA
Outreach and Dissemination Unit$102,000
U54 · FY2010 · CA · contact PI
Developing a single cell growth monitor for classifying therapeutic response$310,506
R21 · FY2009 · CA
Outreach and Dissemination Unit$100,000
U54 · FY2009 · CA · contact PI